Tag Archives: Ebixa

Pharmacological Treatments for Alzheimer’s Disease in Primary Care / Management of Cognitive Symptoms (DTB / Nursing Times)

Summary A Drug and Therapeutics Bulletin (DTB) article reviews the evidence concerning drugs prescribed for cognitive symptoms in Alzheimer’s Disease and discusses some issues in their prescription. Donepezil, galantamine and rivastigmine are licensed for mild to moderate Alzheimer’s Disease in … Continue reading

Posted in Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Management of Condition, Models of Dementia Care, NICE Guidelines, Pharmacological Treatments, Practical Advice, Quick Insights, UK | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Effectiveness and Cost-Effectiveness of Donepezil, Galantamine, Rivastigmine and Memantine for the Treatment of Alzheimer’s Disease (Health Technology Assessment)

[A version of this item appears in: Dementia: the Latest Evidence Newsletter (RWHT), Volume 2 Issue 11, June 2012]. Summary The purpose of this Health Technology Assessment was to review and update guidance to the NHS in England and Wales … Continue reading

Posted in Acute Hospitals, Community Care, For Doctors (mostly), For Researchers (mostly), Management of Condition, National, NHS, NIHR, Pharmacological Treatments, Proposed for Next Newsletter, Systematic Reviews, UK | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Donepezil and Memantine for Moderate-to-Severe Alzheimer’s Disease (NEJM / BBC News)

[A version of this item appears in: Dementia: the Latest Evidence Newsletter (RWHT), Volume 2 Issue 8, March 2012]. Summary A study was performed by researchers at King’s College London, to see whether the benefits of cholinesterase inhibitors for the … Continue reading

Posted in Acute Hospitals, BBC News, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Management of Condition, NHS, Pharmacological Treatments, Practical Advice, Quick Insights, UK, Universal Interest | Tagged , , , , , , , , , | Leave a comment

Update to Dementia on Clinical Knowledge Summaries (Prodigy, formerly CKS)

Summary The Prodigy (formerly Clinical Knowledge Summaries, CKS) topic on Dementia has been updated to include prescribing information for Memantine (Memantine Hydrochloride). Sub-topics comprise: Contraindications. Dose and Titration. Adverse Effects. Drug Interactions. The Basis of Recommendation has been updated to … Continue reading

Posted in For Doctors (mostly), Guidelines, Management of Condition, National, Pharmacological Treatments, Practical Advice, Proposed for Next Newsletter, Quick Insights, UK | Tagged , , , , , , , , , , , | Leave a comment

Treatment of Alzheimer’s Disease (NHS Choices)

Summary This NHS Choices web page gives the layman an easy to understand overview of how Alzheimer’s Disease is likely to be treated. Treatment for Alzheimer’s Disease involves creating a care plan to identify the type of assistance a person is likely to need and clarify … Continue reading

Posted in For Carers (mostly), Management of Condition, National, NHS, NHS Digital (Previously NHS Choices), Quick Insights, Universal Interest | Tagged , , , , , , , , , | Leave a comment

Alzheimer’s Disease: Medicines (NHS Choices)

Summary This NHS Choices web page gives access to overviews of medicines prescribed in the UK for Alzheimer’s Disease. The drugs for which links to information are provided here include: Aricept. Ebixa (a brand of memantine hydrochloride). Exelon. Galantamine hydrobromide. Memantine hydrochloride. Reminyl (a brand … Continue reading

Posted in For Carers (mostly), For Nurses and Therapists (mostly), NHS, NHS Digital (Previously NHS Choices), Patient Information, Pharmacological Treatments, Quick Insights, Universal Interest | Tagged , , , , , , , , | Leave a comment